Example: Heart Attack

Search clinical trials for: Nadolol

Total 21 results





    • NCT00670267
      Completed
      Oral Nadolol for the Treatment of Adults With Mild Asthma
      Conditions: Asthma
    • NCT02505971
      Active, not recruiting
      Nadolol Versus Propranolol in Children With Infantile Hemangiomas
      Conditions: Infantile Hemangioma
    • NCT01010308
      Completed
      Nadolol for Proliferating Infantile Hemangiomas
      Conditions: Infantile Hemangioma
    • NCT00921349
      Completed
      A Trial of Ligation Plus Nadolol Versus Nadolol Alone in the Prophylaxis of First Variceal Bleeding in Cirrhosis
      Conditions: Variceal Bleeding; Cirrhosis
    • NCT00567216
      Unknown status
      Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment in the Prevention of Gastric Variceal Rebleeding
      Conditions: Liver Cirrhosis and Hepatoma.; Gastric Variceal Bleeding
    • NCT01103154
      Completed
      A Trial of Nadolol Plus Isosorbide Mononitrate Versus Carvedilol for the Prevention of Variceal Rebleeding
      Conditions: Variceal Rebleeding
    • NCT00960245
      Completed
      Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions
      Conditions: High Blood Pressure; Migraine Headaches; Chest Pain
    • NCT00648297
      Completed
      Fed Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg
      Conditions: Healthy
    • NCT00647660
      Completed
      Fasting Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg
      Conditions: Healthy
    • NCT01804218
      Unknown status
      Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma
      Conditions: Mild Persistent Asthma, Uncomplicated
    • NCT01825122
      Completed
      Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow Obstruction
      Conditions: Smoking Cessation
    • NCT00910689
      Completed
      Drug and Non-Drug Treatment Of Severe Migraine
      Conditions: Migraine Headache
    • NCT00563602
      Unknown status
      Treatment for Prevention of Variceal Rebleeding Guided by the Hemodynamic Response
      Conditions: Portal Hypertension; Complications of Cirrhosis
    • NCT00450164
      Completed
      Secondary Prophylaxis After Variceal Bleeding in Non-Responders
      Conditions: Gastrointestinal Hemorrhage; Portal Hypertension; Cirrhosis
    • NCT00787436
      Withdrawn
      Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDE
      Conditions: Gastrointestinal Hemorrhage; Portal Hypertension
    • NCT00684489
      Completed
      Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension
      Conditions: Hypertension
    • NCT01282385
      Unknown status
      Hemodynamic Effect of Simvastatin With Beta Blockers in Clinical Portal Hypertension
      Conditions: Liver Cirrhosis; Portal Hypertension.
    • NCT00409084
      Terminated
      Beta Blockers Versus Variceal Band Ligation and Beta Blockers for Primary Prophylaxis of Variceal Bleeding
      Conditions: Esophageal Varices
    • NCT01117454
      Completed
      Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
      Conditions: Catecholaminergic Polymorphic Ventricular Tachycardia
    • NCT04467931
      Active, not recruiting
      ACEI or ARB and COVID-19 Severity and Mortality in US Veterans
      Conditions: Hypertension; COVID
    • NCT01316952
      Completed
      Coreg and HSRs-Updated Analysis
      Conditions: Hypersensitivity
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations